Rachel RennardAssociate Director of In Vitro Discovery at Compass Therapeutics
Profile
Rachel is the head of In Vitro Antibody Discovery and Optimization at Compass Therapeutics. Her expertise is in building antibody discovery platforms, with a focus on phage display technologies.
Rachel Rennard's Network
Agenda Sessions
Optimization of Common Light Chain Bispecific Antibodies
, 5:45pmView Session